T. Rowe Price Investment Management, Inc. Atrion Corp Transaction History

T. Rowe Price Investment Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$381.09 - $495.99 $35.6 Million - $46.4 Million	-93,488 Reduced 67.38%	45,266 $20.5 Million
Q1 2024 May 15, 2024	BUY	$308.3 - $463.55 $7.18 Million - $10.8 Million	23,277 Added 20.16%	138,754 $64.3 Million
Q4 2023 Feb 14, 2024	BUY	$289.29 - $409.7 $1.35 Million - $1.91 Million	4,674 Added 4.22%	115,477 $43.7 Million
Q2 2023 Aug 14, 2023	BUY	$500.0 - $659.0 $3,500 - $4,613	7 Added 0.01%	110,803 $62.7 Million
Q1 2023 May 15, 2023	SELL	$565.0 - $694.87 $2.7 Million - $3.32 Million	-4,774 Reduced 4.13%	110,796 $69.6 Million
Q4 2022 Feb 14, 2023	SELL	$551.1 - $688.5 $9.93 Million - $12.4 Million	-18,020 Reduced 13.49%	115,570 $64.7 Million
Q3 2022 Nov 14, 2022	BUY	$545.43 - $680.3 $72.9 Million - $90.9 Million	133,590 New	133,590 $75.5 Million

114K

Ticker ATRI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 1,785,990
Description
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in vari...

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.